Advertisement
Advertisement
U.S. Markets open in 4 hrs 58 mins
Advertisement
Advertisement
Advertisement
Advertisement

BioElectronics Corporation (BIEL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0012-0.0001 (-7.69%)
At close: 03:59PM EST
Advertisement
Sign in to post a message.
  • t
    tsongbird
    The Acti Patch/ KT Recovery Wave are gaining popularity in Europe as they are looking for pain alternatives to combat opium addiction. For example in "Estonia, previously part of the Soviet Union, joined the EU in 2004. An ongoing issue in Estonia has been the emergence of the Opioid Fentanyl. According to The Economist, more of Estonia’s citizens die from a drug overdose than any other European country. After a bust in 2017 where some of the main suppliers of Fentanyl to Estonia were cut off, users started injecting a mixture of other black market substances. Nine out of 10 patients who seek treatment in Estonia report that Opioids are their primary drugs of use; the majority of patients use Fentanyl." -- Addiction Center-Addiction in the EU

    https://www.desertcart.de/products/48663586-acti-patch-knee-pain-therapy-device
  • t
    tsongbird
    Despite the significant drop on the Nasdaq, BIEL is holding up pretty well. That should tell you something about the credibility of this stock.
    Bullish
  • s
    steve smith
    BIEL appears to be expanding to a huge new facility in New York.
  • A
    Al
    Looking for a 10 Bagger? You had best buy BIEL this week!
  • C
    Coach
    Terry, enlighten all of us if you dare. You’ve been endlessly trashing this company. Making false claims, making up things. And this has been going on for 20 years. You keep crying about paying 40 cents a share. Many have invested poorly, unable to time a market, and lost money. It’s rare that someone holds a resentment for this long, not feeling they have any responsibility for how they invest. Is there something more you’d like to share. People who invest sometimes incorrectly buy high and just time it wrong. You’ve had twenty years to average down and now you could have gotten all your investment back and more. My vitriol towards you is simple. You are attacking something I’m invested in. On the other hand, you attacking me for all the dishonesty you have put forward all these years, just seems to indicate you hate everything. Why don’t you share why you have a deep hatred. Is it a childhood thing or have you just matured into this? However you slice this, explaining your resentment might change my opinion of you. But don’t count on it.
  • V
    Victor
    Release #:812-220316-rl-1238418:
    BIOELECTRONICS CORPORATION ANNOUNCES MAJOR LENDERS FORGOING INTEREST FOR A 3rd CONSECUTIVE YEAR; NEW RESEARCH PROJECTS UNDERWAY (This will be issued Monday a.m.)

    FREDERICK, MARYLAND, January 3, 2021 - BioElectronics Corporation (OTC PINK:BIEL) is pleased to announce that the managers of the firm’s two largest lenders, Ibex LLC and St. John’s LLC, both of which are controlled by Whelan family members, have agreed to forgo interest due on their convertible debt notes for a third consecutive year, through the end of 2022. Kelly Whelan, President & CEO of BioElectronics, stated: “It is the goal of both the BioElectronics’ management team and the Whelan family to bring the Company to sustained profitability as quickly as possible, for the benefit of all shareholders. The Whelan family has collectively forfeited interest in excess of $1.5 million during 2020 and 2021 and will extend forbearance of interest through at least 2022.”

    In other news, the Company has continued its engagements in basic and applied research. Three projects of note were started over the last six months. The first, which is viewed by the Company as basic research, was launched in the Summer of 2021 and aimed at achieving a new intended use (and in all likelihood develop a new medical device) based on our core capabilities in pulsed short-wave therapy (PSWT). The goal is to investigate whether PSWT can serve as a therapeutic intervention for psychological disorders such as depression and anxiety, through brain stimulation. Preliminary physiologic data indicated that it is possible to identify brain waves associated with anxiety, using cutting edge brainwave assessment technology (wireless electroencephalography). The Company is expanding the "brain stimulation project" by collaborating with Dr. Ken McLeod at Binghamton, with the aim of investigating whether PSWT can influence brain wave activity associated with anxiety. Dr. McLeod is a clinical/engineering research consultant to the Company and a world-renowned expert on bioelectromagnetics research.

    The second research project involves determining the effectiveness of our 720 hours medical device to relieve pain and increase functionality in dogs suffering from arthritis. In the Fall of 2021, the Company partnered with a veterinary physiotherapy researcher located in the UK to conduct a study on 70 dogs that have been diagnosed with severe arthritis. In working out the details of the study, our research team of Dr. Sree Koneru, Dr. Ken McLeod and our Chairman, Dr. Richard Staelin, not only made numerous suggestions on how to improve the study protocol, but also came up with a new design modification for our current device – the intent is to increase the likelihood of providing significant pain relief for the treated dogs. The Company has finalized this new design and is working with our manufacturer to produce the needed 70 devices. With a slated start date in mid-January of 2022, the study is expected to be completed by late Spring of 2022.

    The third project also involves an undertaking to determine the effectiveness of the device for a new intended use, i.e., pain reduction and/or improvement in healing rates of chronic wounds. The Company’s management is currently in discussions with a wound research group to conduct a study on whether the RecoveryRx medical device can provide pain relief to those who suffer with chronic lower limb venous ulcers. A venous leg ulcer is the most common type of leg ulcer, accounting for more than 90% of all cases. Venous leg ulcers can develop after a minor injury, where persistently high pressure in the veins of the legs has damaged the skin. While the name of this group cannot yet be disclosed, their team is recognized internationally for being at the forefront of wound healing research. Their large patient volume affords them the ability to conduct clinical trials quickly and efficiently, with more than 100 clinical trials conducted on growth factors, gene therapy, bioengineered skin products and novel pharmaceuticals. Their research efforts have produced more than 130 abstracts, 100 manuscripts and 900 presentations worldwide.

    Finally, BioElectronics is actively seeking partners towards our goal of expanding our technology’s indications for use. Specifically, the goal is to put together a basic and applied research plan for various clinical disorders that are closely linked to the etiology behind many types of chronic pain, i.e. central sensitization. Some of these disorders include, but are not limited to, overactive bladder (about 33 million Americans have overactive bladder), vulvodynia (as many as 16 percent of women in the U.S. suffer from vulvodynia at some point in their lives), and other treatment-resistant conditions. These approaches are in line with our overall goal of continuing to invest in research and development.
    Biel$$$
  • H
    Hempscam2020
    The Pumpers here ( Dentition: A Biel Pumper is an individual holding large quantities of Biel stock bought at significantly higher prices and are hoping to get other VICTIMS to buy their mistake) now know it is coming to a close, 13 day's into the new year, the bump is over, trips are calling and the nail in the coffin is the YEAR END REPORT.
  • C
    Coach
    Here’s the definition of not a pumper and not a basher. An HONEST person with GOOD character. It also helps if you bought at .0003. Lmfao
  • t
    tsongbird
    Get ready for the climb.
    Bullish
  • s
    steve smith
    The Redd-- surge is coming soon!!!
  • s
    steve smith
    BIEL #25 on Breakout Board. For perspective: Tesla #50, Bitcoin #4.
  • t
    tsongbird
    Wow! Would ya look at that! BIEL is on the rise!
  • V
    Victor
  • C
    Coach
    .0003 to .0014. Every thousandth of a penny rise=$$$$$$$$$$. So sorry.
  • s
    steve smith
    Just added to Red--- Hot Penny Stocks List!
  • t
    tsongbird
    Actipatch is being used by medical professionals in Estonia. How cool is that?!

    https://msa.sm.ee/ctrl/en/MeditsiiniSeade/index/0/5736
  • A
    Anonymous
    I own shares and use the product all the time. It is amazing. I have nerve damage in my neck and knee and it is the only thing that settles it down. I cannot squat down without a lot of pain. Within 5-10 minutes of putting it on, I can do a full squat with only minor pain. Used it post-op after having my shoulder rebuilt last year. Way better than pain meds for nerve damage pain, muscle spasms and regular pain. With doctors not wanting to provide pain meds, why not recommend this? I found out about it from my Pain Management doctor. I have recommended it to friends and family and they all found it to be successful at reducing pain. I have introduced to my GP and two orthopedic docs and they had never even heard of it until I told them about it. One of them tried it on his arthritic knee and thinks it is great. He now recommends it to his patients. It just needs a better Marketing strategy. It is ridiculous that specialists that deal with joint pain have never heard of it. Word of mouth will not make this product a success.
    Bullish
Advertisement
Advertisement